Oxidative Base Damage to Telomeres Sensitizes Cancer Cells to ATR Inhibition

Area of Science:

• Molecular Biology
• Cancer Research
• Genetics

Background:

• PARP inhibitors highlight the clinical relevance of targeting DNA damage response proteins.
• Cancer cells rely on the G2/M checkpoint for survival under replication stress due to G1/S checkpoint loss.
• Telomere oxidative damage can induce replication stress without significant cellular harm.

Purpose of the Study:

• To investigate the therapeutic potential of inhibiting ATR, Chk1, or Wee1 in conjunction with telomere oxidative stress.
• To determine the mechanism by which telomere damage and cell cycle checkpoint inhibition impact cancer cells.
• To assess the efficacy of this combined approach in cancer cells compared to non-cancer cells.

Main Methods:

• Induction of oxidative base damage (8-oxo-guanine) specifically at telomeres.
• Inhibition of key DNA damage response proteins: ATR, Chk1, and Wee1.
• Assessment of genome instability, cell viability, and cell cycle progression.

Main Results:

• Inhibiting ATR, Chk1, or Wee1 post-telomere oxidative stress induction significantly increased genome instability and reduced cancer cell viability.
• These effects were observed at lower doses in cancer cells compared to non-cancer cells.
• The mechanism involves premature G2/M phase exit with unrepaired telomere damage, prolonging mitosis.

Conclusions:

• Targeted oxidative base damage at telomeres can sensitize cancer cells to ATR inhibition.
• This strategy enhances the therapeutic efficacy of ATR inhibitors in cancer treatment.
• The findings suggest a novel approach for cancer therapy by exploiting telomere-specific damage and checkpoint inhibition.